University of Alabama Birmingham
Challenges Of Lutetium-177 Metastable Concentration In Radiopharmaceutical Waste
Abstract
dc:description.abstractLutetium-177 (Lu-177) is an upcoming radiopharmaceutical with commercial use recently approved for cancer treatment by the Federal Drug Administration (FDA). During production, a contaminate, Lutetium-177 metastable (Lu-177m), can also be produced. The concentration of Lu-177m will vary greatly depending on the production method. One of the largest problems posed by this metastable contaminant is disposal challenges due to its longer half-life and more energetic decay process. This research models the potential for the decay in storage method to be used for disposal of Lu-177 waste based on the concentration of Lu-177m. Utilizing varying ratios of metastable per therapeutic dose, this research models Lu-177m concentration versus decay time to determine concentrations of Lu-177m that may be decayed in storage. The goal of this research is to determine the concentration of Lu-177m in the total activity of therapeutic lutetium that vendors can offer to hospitals while verifying that the material will remain below regulatory standards for decay in storage, thereby alleviating the waste challenges associated with accumulation.
Degree
thesis:*- Name thesis:degree_name
- Master of Science (MS)
- Level thesis:degree_level
- Thesis
- Discipline thesis:degree_discipline
- Health Professions
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Liggitt, Cameron Robert
- Contributors dc:contributor
-
- <p>Emily Caffrey</p>
- <p>Charles Wilson<br>Remo George</p>
Subjects
dc:subject × 1Identifiers
dc:identifier.*- Repository record dc:identifier
- https://digitalcommons.library.uab.edu/etd-2020s/183